FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

783435000: Tagraxofusp (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3758934013 Tagraxofusp en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3758935014 Tagraxofusp (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3758934013 Tagraxofusp en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3758935014 Tagraxofusp (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tagraxofusp Is a Interleukin-3 receptor alpha antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Tagraxofusp Is a Recombinant protein (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Tagraxofusp Has disposition Interleukin 3 receptor alpha antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Tagraxofusp Is a Antineoplastic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing tagraxofusp (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tagraxofusp Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only tagraxofusp (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tagraxofusp Inferred relationship Existential restriction modifier (core metadata concept) 1
Tagraxofusp-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tagraxofusp Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only tagraxofusp in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tagraxofusp Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start